Centessa Pharmaceuticals Announces $300 Million Financing Agreement with Oberland Capital
New $300 million facility, combined with Company’s cash balance as of June 30, 2021, provides access to over $900 million to advance development programs and enable pursuit of strategic business development opportunities.